Transcriptional tools: Small molecules for modulating CBP KIX-dependent transcriptional activators

Caleb A. Bates, William C. Pomerantz, Anna K. Mapp

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Previously it was demonstrated that amphipathic isoxazolidines are able to functionally replace the transcriptional activation domains of endogenous transcriptional activators. In addition, in vitro binding studies suggested that a key binding partner of these molecules is the CREB Binding Protein (CBP), more specifically the KIX domain within this protein. Here we show that CBP plays an essential role in the ability of isoxazolidine transcriptional activation domains to activate transcription in cells. Consistent with this model, isoxazolidines are able to function as competitive inhibitors of the activators MLL and Jun, both of which utilize a binding interaction with KIX to up-regulate transcription. Further, modification of the N2 side chain produced three analogs with enhanced potency against Jun-mediated transcription, although increased cytotoxicity was also observed. Collectively these small KIX-binding molecules will be useful tools for dissecting the role of the KIX domain in a variety of pathological processes.

Original languageEnglish (US)
Pages (from-to)17-23
Number of pages7
JournalBiopolymers
Volume95
Issue number1
DOIs
StatePublished - Jan 1 2011

Fingerprint

CREB-Binding Protein
Transcription
Transcriptional Activation
Molecules
Pathologic Processes
Chemical activation
Up-Regulation
Cytotoxicity
Proteins
Carrier Proteins
In Vitro Techniques
Protein Domains

Keywords

  • Domain
  • Isoxazolidine
  • Jun
  • MLL
  • Transcriptional activation
  • Transcriptional activator

Cite this

Transcriptional tools : Small molecules for modulating CBP KIX-dependent transcriptional activators. / Bates, Caleb A.; Pomerantz, William C.; Mapp, Anna K.

In: Biopolymers, Vol. 95, No. 1, 01.01.2011, p. 17-23.

Research output: Contribution to journalArticle

@article{32709a716922478dbeb3f79afda856f3,
title = "Transcriptional tools: Small molecules for modulating CBP KIX-dependent transcriptional activators",
abstract = "Previously it was demonstrated that amphipathic isoxazolidines are able to functionally replace the transcriptional activation domains of endogenous transcriptional activators. In addition, in vitro binding studies suggested that a key binding partner of these molecules is the CREB Binding Protein (CBP), more specifically the KIX domain within this protein. Here we show that CBP plays an essential role in the ability of isoxazolidine transcriptional activation domains to activate transcription in cells. Consistent with this model, isoxazolidines are able to function as competitive inhibitors of the activators MLL and Jun, both of which utilize a binding interaction with KIX to up-regulate transcription. Further, modification of the N2 side chain produced three analogs with enhanced potency against Jun-mediated transcription, although increased cytotoxicity was also observed. Collectively these small KIX-binding molecules will be useful tools for dissecting the role of the KIX domain in a variety of pathological processes.",
keywords = "Domain, Isoxazolidine, Jun, MLL, Transcriptional activation, Transcriptional activator",
author = "Bates, {Caleb A.} and Pomerantz, {William C.} and Mapp, {Anna K.}",
year = "2011",
month = "1",
day = "1",
doi = "10.1002/bip.21548",
language = "English (US)",
volume = "95",
pages = "17--23",
journal = "Biopolymers",
issn = "0006-3525",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Transcriptional tools

T2 - Small molecules for modulating CBP KIX-dependent transcriptional activators

AU - Bates, Caleb A.

AU - Pomerantz, William C.

AU - Mapp, Anna K.

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Previously it was demonstrated that amphipathic isoxazolidines are able to functionally replace the transcriptional activation domains of endogenous transcriptional activators. In addition, in vitro binding studies suggested that a key binding partner of these molecules is the CREB Binding Protein (CBP), more specifically the KIX domain within this protein. Here we show that CBP plays an essential role in the ability of isoxazolidine transcriptional activation domains to activate transcription in cells. Consistent with this model, isoxazolidines are able to function as competitive inhibitors of the activators MLL and Jun, both of which utilize a binding interaction with KIX to up-regulate transcription. Further, modification of the N2 side chain produced three analogs with enhanced potency against Jun-mediated transcription, although increased cytotoxicity was also observed. Collectively these small KIX-binding molecules will be useful tools for dissecting the role of the KIX domain in a variety of pathological processes.

AB - Previously it was demonstrated that amphipathic isoxazolidines are able to functionally replace the transcriptional activation domains of endogenous transcriptional activators. In addition, in vitro binding studies suggested that a key binding partner of these molecules is the CREB Binding Protein (CBP), more specifically the KIX domain within this protein. Here we show that CBP plays an essential role in the ability of isoxazolidine transcriptional activation domains to activate transcription in cells. Consistent with this model, isoxazolidines are able to function as competitive inhibitors of the activators MLL and Jun, both of which utilize a binding interaction with KIX to up-regulate transcription. Further, modification of the N2 side chain produced three analogs with enhanced potency against Jun-mediated transcription, although increased cytotoxicity was also observed. Collectively these small KIX-binding molecules will be useful tools for dissecting the role of the KIX domain in a variety of pathological processes.

KW - Domain

KW - Isoxazolidine

KW - Jun

KW - MLL

KW - Transcriptional activation

KW - Transcriptional activator

UR - http://www.scopus.com/inward/record.url?scp=78049442211&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78049442211&partnerID=8YFLogxK

U2 - 10.1002/bip.21548

DO - 10.1002/bip.21548

M3 - Article

C2 - 20882601

AN - SCOPUS:78049442211

VL - 95

SP - 17

EP - 23

JO - Biopolymers

JF - Biopolymers

SN - 0006-3525

IS - 1

ER -